404
Hemoglobinopathy Market Report
Hemoglobinopathy Market Trends, Dynamics & Market Insights
Hemoglobinopathy Market, By Indication (Sickle cell disease, Alpha thalassemia, Beta thalassemia), Test Type (Blood Count, Platelet Function, Hemoglobin, Hematocrit), End-Use (Hospitals, Diagnostic Laboratories, Clinics), and Region
The hemoglobinopathy market is expected to witness an impressive growth of 10.6% CAGR in the coming years.
Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Mindray Medical International Limited (China), Nexcelom Bioscience (US), Nihon Kohden Corporation (Ja-pan), PerkinElmer (US), Siemens Healthineers AG (Germany) and Sysmex Corporation (Japan) are among the key players in the hemoglobinopathy market.
The hemoglobinopathy market size is expected to reach USD 13.2 billion in the foreseeable future.
The hospitals' segment is expected to register significant growth in the hemoglobinopathy market in the coming years.
North America accounted for the largest share in the hemoglobinopathy market in 2020.
Hemoglobinopathy distributors, Hemoglobinopathy suppliers, Hemoglobinopathy manufacturers, Logistics organizations, Government bodies are the target audience in the hemoglobinopathy market.